Table 3:
Male |
Female |
|||
---|---|---|---|---|
AI/AN AAPC | White AAPC | AI/AN AAPC | White AAPC | |
Cancer Sites | ||||
All sites | −0.4 | −1.4* | 0.5 | −0.3 |
Lung | −0.3 | −2.3* | −0.6* | 0.0 |
CRC | −1.1* | −3.3* | −0.5 | −2.4* |
Prostate | −4.0* | −4.0* | NA | NA |
Breast | NA | NA | 0.9* | −0.6 |
Kidney | 2.4* | 1.8* | 1.6* | 1.7* |
Liver | 3.3* | 3.5* | 4.2* | 2.5* |
Stomach | −1.6* | −1.5* | −1.3 | −1.5 |
Cervical | NA | NA | 0.0 | −1.2* |
Note: AI/AN= American Indian Alaska Native; AAPC= average annual percent change; PRCDA=Purchased/Referred Care Delivery Areas.
Joinpoint Analyses with up to 3 joinpoints are based on rates per 100,000 persons and were age-adjusted to the 2000
US standard population ( 11 age groups; census P25–1130); Joinpoint Regression Program, Version 4.0.1. January 2013; Statistical Research and Applications Branch, National Cancer Institute
Bethesda, MD. Analyses are limited to persons of non-Hispanic origin. AI/AN race is reported through linkage with the Indian Health Service patient registration database.
APC is based on rates that were age-adjusted to the 2000 US standard population (11 age groups, Census P25–1130).
2-sided P<0.05